ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Califano Insists On Search Committee To Look for NCI Chief; Brown Still In Running

February 25, 1977

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999